欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0476/001
药品名称Stamaril (mono and multi-dose)
活性成分
    • Yellow-fever virus, live attenuated 1000.0 LD50
剂型Powder and solvent for suspension for injection
上市许可持有人Sanofi Pasteur Europe
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Cyprus (CY)
      Stamaril
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      STAMARIL Pulver &Lösungsmittel zur Herstellung einer Injektionssuspension Gelbfieber-Lebendimpfstoff
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Stamaril Pasteur
    • Latvia (LV)
      Stamaril Pasteur powder and solvent for suspension for injection
    • Lithuania (LT)
      STAMARIL milteliai ir tirpiklis injekcinei suspensijai
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
      STAMARIL
    • Czechia (CZ)
      12496/07
    • Romania (RO)
      Stamaril
    • Slovakia (SK)
      STAMARIL
    • Malta (MT)
      Stamaril Powder & Solvent for Suspension for Injection not less 1000LD units
许可日期2008/04/05
最近更新日期2024/07/10
药物ATC编码
    • J07BL01 yellow fever, live attenuated
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase